Skip to content
← Holders

DAFNA Capital Management LLC

What DAFNA Capital Management LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1389933 · Filed Nov 16, 2026

Positions
87
Reported value
$468.1M
Opened
5
Closed
6
Other managers included
1

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$404.8M
    75 positions
  2. Dec 31, 2025$430.5M
    77 positions
  3. Mar 31, 2026$439.6M
    83 positions
  4. Jun 30, 2026$524.4M
    88 positions
  5. Sep 30, 2026$468.1M
    87 positions
SecuritySharesChangeValueOf portfolio
RVMDRevolution Medicines, Inc.
487.1K−13.4%$100M21.4%
ATRCAtriCure, Inc.
522.7K−12.5%$29.4M6.3%
CMPSCOMPASS Pathways plc
2.1M+6.2%$26.6M5.7%
SPDR S&P BIOTECH ETFETF
151.5K−22.9%$23.9M5.1%
NKTRNektar Therapeutics
323.4K+1.6%$19.6M4.2%
IDYAIDEAYA Biosciences, Inc.
438.7K−11.8%$16.9M3.6%
STXSStereotaxis, Inc.
13.7M±0%$16.8M3.6%
DNLIDenali Therapeutics Inc.
744K+0.7%$15.4M3.3%
ASNDAscendis Pharma A/S
50K+3.1%$11.4M2.4%
RCUSArcus Biosciences, Inc.
439.8K−0.5%$11.4M2.4%
CYTKCytokinetics Inc
172K±0%$11.3M2.4%
EWTXEdgewise Therapeutics, Inc.
221.8K−2.2%$9M1.9%
NBIXNeurocrine Biosciences Inc
62.7K+8.6%$8.9M1.9%
PODDInsulet Corp
67.9K+9.7%$8.9M1.9%
XENEXenon Pharmaceuticals Inc.
204.8K−18.3%$7.6M1.6%
AXGNAxogen, Inc.
180K−13.9%$7.5M1.6%
DXCMDexCom Inc
86.3K±0%$7.4M1.6%
SNDXSyndax Pharmaceuticals Inc
331.3K−1.2%$6.2M1.3%
LRMRLarimar Therapeutics, Inc.
1.9M−6.0%$6M1.3%
TNDMTandem Diabetes Care Inc
355.2KNew$5.8M1.2%
BCAXBicara Therapeutics Inc.
300K+5.3%$5.6M1.2%
RAPPRapport Therapeutics, Inc.
141.9K+89.2%$4.8M1%
IMVTImmunovant, Inc.
135.5K−9.4%$4.6M1%
INGNInogen Inc
845.2K±0%$4.5M1%
NGNENeurogene Inc.
150.5K+69.1%$4.2M0.9%
ALKSAlkermes plc.
101.3K±0%$4.1M0.9%
IPSCCentury Therapeutics, Inc.
2.4M−0.6%$4.1M0.9%
KIDSOrthopediatrics Corp
179.1K−5.3%$4M0.9%
LKFTLakefront Biotherapeutics NV
130.2K±0%$3.9M0.8%
STOKStoke Therapeutics, Inc.
146.1K+11.7%$3.8M0.8%
ANLAdlai Nortye Group Ltd.
232.8K−2.8%$3.7M0.8%
EPRXEupraxia Pharmaceuticals Inc.
404.6K+79.3%$3.7M0.8%
CLDXCelldex Therapeutics, Inc.
108.1K+57.8%$3.5M0.7%
ALLOAllogene Therapeutics, Inc.
2M±0%$3.2M0.7%
BCRXBiocryst Pharmaceuticals Inc
380.2K−5.0%$3.2M0.7%
KYMRKymera Therapeutics, Inc.
26.9K−0.3%$3M0.6%
AQSTAquestive Therapeutics, Inc.
640.9K−0.8%$3M0.6%
RNAAtrium Therapeutics, Inc.
300.1K+134.4%$2.5M0.5%
ISHARES NASDAQ BIOTECH INDXETF
11.6K−72.8%$2.4M0.5%
PRCTPROCEPT BioRobotics Corp
120K±0%$2.2M0.5%
PRQRProQR Therapeutics N.V.
1.3M−14.2%$2.2M0.5%
HELPHelus Pharma Inc.
175.7K−65.8%$2.2M0.5%
ALGNAlign Technology Inc
14K±0%$2M0.4%
VKTXViking Therapeutics, Inc.
54.5K−8.4%$1.8M0.4%
MAZEMaze Therapeutics, Inc.
65K±0%$1.8M0.4%
ALECAlector, Inc.
908.4K±0%$1.7M0.4%
TELATELA Bio, Inc.
1.4M±0%$1.7M0.4%
MPLTMapLight Therapeutics, Inc.
155.6K−9.0%$1.6M0.3%
NGENNervgen Pharma Corp.
810.9K−22.8%$1.5M0.3%
GPCRStructure Therapeutics Inc.
46.5K±0%$1.5M0.3%
PROFProfound Medical Corp.
225.1K−13.5%$1.3M0.3%
MDWDMediWound Ltd.
94.4K±0%$1.3M0.3%
DSGNDesign Therapeutics, Inc.
102.1K−0.5%$1.3M0.3%
LXEOLexeo Therapeutics, Inc.
377.1K±0%$1.3M0.3%
INSPInspire Medical Systems, Inc.
18.2K±0%$1.3M0.3%
CTMXCytomX Therapeutics, Inc.
438.4K±0%$1.2M0.3%
FATEFate Therapeutics Inc
500K−4.8%$1.2M0.3%
MLYSMineralys Therapeutics, Inc.
44.5K±0%$1.1M0.2%
PYPDPolyPid Ltd.
207.9K±0%$1.1M0.2%
BBOTBridgeBio Oncology Therapeutics, Inc.
266KNew$1.1M0.2%
ANNXAnnexon, Inc.
257.6K−13.5%$1.1M0.2%
BHVNBiohaven Ltd.
77.6K−43.6%$1M0.2%
IMTXImmatics N.V.
117K±0%$1M0.2%
QTTBQ32 Bio Inc.
98.5K+199.4%$814.6K0.2%
PYXSPyxis Oncology, Inc.
344.8KNew$803.4K0.2%
SPRYARS Pharmaceuticals, Inc.
182.8K+11.3%$787.8K0.2%
RAREUltragenyx Pharmaceutical Inc.
51.1K+8.5%$768K0.2%
KURAKura Oncology, Inc.
69.1K−42.7%$739.7K0.2%
BNTXBioNTech SE
7K±0%$688.1K0.1%
SCYXScynexis Inc
135.9K±0%$671.2K0.1%
ACETAdicet Bio, Inc.
93.8K±0%$669.8K0.1%
SPTXSeaport Therapeutics, Inc.
32.4K±0%$653.5K0.1%
QNRXQuoin Pharmaceuticals Ltd.
132.2KNew$602.6K0.1%
CRBPCorbus Pharmaceuticals Holdings, Inc.
83.2K−22.8%$567.8K0.1%
PLRXPliant Therapeutics, Inc.
487K±0%$526K0.1%
EDITEditas Medicine, Inc.
180.5K+5.9%$463.8K0.1%
ARAYAccuray Inc
1.7M±0%$453.9K0.1%
CGENCompugen Ltd
168.2K±0%$400.4K0.1%
AUTLAutolus Therapeutics plc
179.3K±0%$347.9K0.1%
FHTXFoghorn Therapeutics Inc.
89.7K−19.8%$320.1K0.1%
IBIOiBio, Inc.
170.1K±0%$200.7K0.1%
TNYATenaya Therapeutics, Inc.
300K±0%$181.1K0.1%
KZIAKazia Therapeutics Ltd
15.7KNew$150.6K0.1%
ENGNenGene Therapeutics Inc.
74.7K±0%$149.3K0.1%
VRCAVerrica Pharmaceuticals Inc.
23.8K±0%$113.9K0.1%
KARDKardigan, Inc.
5K±0%$73.8K0.1%
ADCTADC Therapeutics SA
57.1K−25.9%$69.6K0.1%